Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 02:20PM ET
105.32
Dollar change
+1.16
Percentage change
1.11
%
IndexS&P 500 P/E16.51 EPS (ttm)6.38 Insider Own1.07% Shs Outstand90.41M Perf Week3.80%
Market Cap9.62B Forward P/E12.38 EPS next Y8.51 Insider Trans-0.99% Shs Float90.33M Perf Month31.50%
Income595.52M PEG0.90 EPS next Q1.61 Inst Own89.59% Short Float / Ratio7.45% / 4.97 Perf Quarter10.22%
Sales11.91B P/S0.81 EPS this Y17.52% Inst Trans-2.61% Short Interest6.73M Perf Half Y5.23%
Book/sh13.13 P/B8.02 EPS next Y9.65% ROA3.51% Target Price104.43 Perf Year42.65%
Cash/sh6.10 P/C17.27 EPS next 5Y18.27% ROE68.77% 52W Range70.80 - 116.97 Perf YTD41.05%
Dividend- P/FCF7.29 EPS past 5Y10.46% ROI5.04% 52W High-9.96% Beta1.01
Dividend %- Quick Ratio1.19 Sales past 5Y1.33% Gross Margin24.32% 52W Low48.76% ATR2.80
Employees70000 Current Ratio1.24 Sales Q/Q5.85% Oper. Margin12.13% RSI (14)74.38 Volatility2.91% 3.13%
OptionableYes Debt/Eq9.28 EPS Q/Q132.13% Profit Margin5.00% Rel Volume0.36 Prev Close104.16
ShortableYes LT Debt/Eq8.86 EarningsNov 07 AMC Payout0.00% Avg Volume1.35M Price105.32
Recom2.78 SMA209.05% SMA5019.33% SMA20013.77% Volume368,494 Change1.11%
Date Action Analyst Rating Change Price Target Change
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Jan-24-20Upgrade Goldman Neutral → Buy $72 → $97
Today 11:31AM
Nov-30-23 10:00AM
Nov-28-23 06:30AM
04:03AM
Nov-27-23 11:20AM
09:07AM Loading…
09:07AM
Nov-22-23 10:40AM
09:40AM
Nov-15-23 11:54PM
Nov-13-23 09:31AM
Nov-10-23 12:00PM
Nov-09-23 09:55AM
Nov-08-23 05:46PM
12:22PM
10:56AM
07:27AM Loading…
07:27AM
01:33AM
Nov-07-23 10:07PM
08:30PM
04:44PM
04:40PM
04:05PM
09:40AM
Nov-06-23 09:40AM
Nov-03-23 12:21PM
Nov-02-23 12:05PM
Oct-25-23 12:33PM
Oct-24-23 07:00AM
Oct-23-23 10:15AM
09:40AM
08:00AM Loading…
08:00AM
Oct-20-23 09:40AM
Oct-18-23 04:52PM
12:00PM
11:10AM
11:05AM
10:59AM
10:10AM
Oct-17-23 06:26PM
11:34AM
10:08AM
Oct-16-23 10:39AM
10:38AM
Oct-13-23 12:41PM
Oct-12-23 12:55PM
11:07AM
11:03AM
08:47AM
08:37AM
08:30AM
Oct-11-23 03:57PM
01:01PM
12:43PM
12:28PM
12:17PM
11:52AM
11:33AM
11:25AM
10:47AM
10:45AM
10:22AM
10:04AM
09:40AM
06:02AM
Oct-10-23 12:03PM
11:57AM
11:28AM
10:10AM
10:02AM
09:40AM
09:10AM
Oct-09-23 11:15AM
11:15AM
11:08AM
10:47AM
09:58AM
Oct-06-23 12:11PM
12:03PM
11:33AM
Oct-05-23 11:05AM
10:45AM
10:09AM
10:08AM
Oct-04-23 12:32PM
11:40AM
11:29AM
11:27AM
10:17AM
Oct-03-23 11:21AM
Oct-02-23 09:40AM
Sep-29-23 07:20PM
12:20PM
10:15AM
Sep-28-23 08:26PM
12:01PM
09:49AM
Sep-27-23 06:46PM
10:59AM
09:55AM
09:37AM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 22Option Exercise52.4140,0002,096,400121,297Aug 24 06:54 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 22Sale101.819,794997,09981,297Aug 24 06:54 PM
YALE PHYLLIS RDirectorMay 12Option Exercise66.297,165474,96820,275May 12 09:31 PM
YALE PHYLLIS RDirectorMay 12Sale95.262,196209,19513,110May 12 09:31 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMay 10Option Exercise66.29243,99416,174,362348,071May 12 09:34 PM
Rodriguez JavierChief Executive OfficerMay 10Option Exercise66.2988,2135,847,640403,835May 12 09:20 PM
ACKERMAN JOELCFO and TreasuerMay 10Option Exercise66.2956,3063,732,525191,097May 12 08:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 10Option Exercise66.2933,7842,239,541135,164May 12 09:15 PM
HEARTY JAMES OChief Compliance OfficerMay 10Option Exercise66.2926,2761,741,83658,835May 12 08:48 PM
DESOER BARBARA JDirectorMay 10Option Exercise66.297,165474,9687,165May 12 08:46 PM
NEHRA JOHN MDirectorMay 10Option Exercise66.297,165474,9687,165May 12 08:50 PM
Rodriguez JavierChief Executive OfficerMay 10Sale99.4416,9161,682,089315,622May 12 09:20 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 10Sale99.2415,9411,581,99091,245May 12 09:15 PM
HEARTY JAMES OChief Compliance OfficerMay 10Sale101.645,745583,91432,559May 12 08:48 PM
DESOER BARBARA JDirectorMay 10Sale101.612,449248,8430May 12 08:46 PM
BERG CHARLESDirectorMar 09Sale75.131,431107,51315,733Mar 13 06:04 PM
BERG CHARLESDirectorMar 01Sale81.7873560,10817,164Mar 02 05:42 PM
BERG CHARLESDirectorFeb 28Option Exercise66.297,165474,96823,633Mar 02 05:42 PM
BERG CHARLESDirectorFeb 24Option Exercise65.943,601237,45019,334Feb 27 06:18 PM